Metabolism 101 Flashcards
(25 cards)
Long chain fatty acid degradation site
Transport of Fatty Acyl-CoA from the cytosol into the mitochondria (via carnitine shuttle transport)
Systemic Primary carnitine deficiency
Inherited defect in transport of Long chain fatty acids into the mitochondria (defect in carnitine shuttle)
Causes weakness, hypotonia and hypoketotic hypoglycemia
Fatty acid synthesis rate limiting enzyme
Acetyl CoA carboxylase
Fatty acid oxidation rate limiting enzyme
Carnitine acyltransferase I
Ketone bodies
Acetone, acetic state and beta hydroxybutyrate
Causes of increased ketone body synthesis
Ketoacidosis: oxaloacetate is depleted for gluconeogenesis
Alcoholism: excess NADH shunts oxaloacetate to malate
BOTH PROCESSES–> increased acetyl CoA
Acetyl CoA converted to acetoacetate and beta hydroxybutyrate in liver and delivered to extrahepatic tissues
Fuel use after eating: Fed state
Glycolysis and aerobic respiration
Fatty acid synthesis site
Transport citrate from mitochondria to the cytosol (via citrate shuttle)
Occurs in liver, lactating mammary glands and adipose tissue
Fuel Use: starvation days 1-3
Hepatic glucogenolysis
Adipose release of FFA
Energy use of FFA in muscle and liver
GLYCOGEN IS DEPLETED AFTER ONE DAY OF FASTING
Fuel Use: starvation 3+ days
Adipose stores: ketones become the main source of energy for the brain
After adipose is depleted, vital protein is degenerated –>organ failure and death
Excess adipose stores determine length of survival
Cholesterol synthesis
Acetyl CoA precursor
Enzyme: HMG CoA reductase
Lipoprotein Lipase
Degradation of triglycerides circulating in chylomicrons and VLDL’s
On vascular endothelial surface
Hepatic TG lipase
Degradation of TG remaining in IDL
Hormone sensitive lipase
Degredation of TG’s stored in adipocytes
LCAT
Takes “nascent”/immature HDL and adds cholesterol to it to form a mature HDL particle
Cholesterol ester transfer protein (CETP)
Mediates transfer of cholesterol esters to other lipoprotein particles
Takes cholesterol esters from mature HDL, transfers them to VLDL, IDL and LDL in exchange for triglycerides
ApoE
Mediates remnant uptake
Chylomicrons, chylomicrons remnant, VLDL, IDL and HDL
EVERYONE (besides LDL) gets ApoE
ApoA-I
Activates LCAT
Chylomicrons and HDL
ApoC II
Lipoprotein lipase cofactor
Chylomicron, VLDL and HDL
ApoB48
mediates chylomicron secretion
Chylomicron/chylomicron remnant
ApoB 100
Binds LDL receptor
VLDL, IDL and LDL
Familial dyslipidemia type I
Autosomal recessive
LPL or ApoCII deficiency
Increased TG, chylomicrons and cholesterol
Clinical s/s: pancreatitis, hepatosplenomegaly, pruritic xanthomas
Creamy layer of supernatent
Familial hypercholesterolemia
Type II
Autosomal dominant Absent or defective LDL receptors Increased LDL, cholesterol Heterozygotes: 300 cholesterol Homozygous: 700+ (very rare) Accelerated atherosclerosis: MI before age 20, tendon xanthomas, corneal arcus
Hypertriglyceridemia
Type IV
Autosomal dominant
Hepatic overproduction of VLDL
Increased VLDL, TG
Hypertriglyceridemia–>acute pancreatitis (>1000 for TG’s)